Showing results (161-170 of 906) with videos related to
Sort By:
Pageof 91
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 29, 2019
Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trialsSusan Stienen, Patrick Rossignol, António Barros, et al.International Journal of Cardiology|April 18, 2009
Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trialBertram Pitt, Faiez Zannad, Mihai Gheorghiade, et al.American Journal of Hypertension|June 1, 2005
Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal womenRichard A Preston, William B White, Bertram Pitt, et al.Journal of Cardiac Failure|May 19, 2025
Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial DesignJoão Pedro Ferreira, Pedro Marques, Ana Rita Leite, et al.American Heart Journal|December 12, 2017
Mineralocorticoid receptor antagonists in patients with acute myocardial infarction - A systematic review and meta-analysis of randomized trialsMatthias Bossard, Yasser Binbraik, Farzin Beygui, et al.American Journal of Hypertension|December 12, 2017
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection FractionPatrick Rossignol, Brian Lee Claggett, Jiankang Liu, et al.European Heart Journal|March 3, 2020
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trialMichael Böhm, João Pedro Ferreira, Felix Mahfoud, et al.Journal of the American College of Cardiology|August 3, 2019
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection FractionJasper Tromp, Li Shen, Pardeep S Jhund, et al.Journal of the American College of Cardiology|August 27, 2025
Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical TrialsJohn W Ostrominski, Mats C Højbjerg Lassen, Jawad H Butt, et al.Journal of the American College of Cardiology|September 2, 2025
Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection FractionJohn W Ostrominski, Brendon L Neuen, Brian L Claggett, et al.Pageof 91